Cappello Joseph
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Cappello Joseph. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GNLX | Chief Technical Officer | Sale | 1,463 | $3.36 | $4,916 | Nov 17, 2025 |
| GNLX | Chief Technical Officer | Award / Grant | 107,500 | — | — | Aug 27, 2025 |
| GNLX | VP, Pharmaceutical Development | Sale | 4,737 | $2.92 | $13,832 | May 12, 2025 |
| GNLX | VP, Pharmaceutical Development | Award / Grant | 13,350 | — | — | Mar 14, 2025 |
| GNLX | VP, Pharmaceutical Development | Award / Grant | 29,000 | — | — | Dec 18, 2024 |
| GNLX | VP, Pharmaceutical Development | Sale | 6,300 | $2.34 | $14,742 | Dec 16, 2024 |
| GNLX | VP, Pharmaceutical Development | Award / Grant | 3,661 | — | — | Mar 14, 2024 |
| GNLX | VP, Pharmaceutical Development | Sale | 3,265 | $23.73 | $77,478 | Aug 18, 2023 |
| GNLX | VP, Pharmaceutical Development | Award / Grant | 9,000 | — | — | Feb 17, 2023 |